[1] 唐春霖, 李锐, 张晓航, 等. 具有肝硬化基础的肝内胆管细胞癌的超声造影及增强CT的增强模式分析. 中华医学超声杂志(电子版), 2011, 8(7):1439-1444. [2] Davila JA, El-Serag HB. Cholangiocarcinoma: the "other" liver cancer on the rise. Am J Gastroenterol, 2002, 97(12):3199-3200. [3] Xu HX, Chen LD, Liu LN, et al. Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination. Br J Radiol, 2012, 85(1016):1029-1037. [4] Mavros MN, Economopoulos KP, Alexiou VG, et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg, 2014,149(6):565-574. [5] Kong WT, Wang WP, Zhang WW, et al. Contribution of contrast-enhanced sonography in the detection of intrahepatic cholangiocarcinoma. J Ultrasound Med, 2014, 33(2):215-220. [6] Quaia E. Assessment of tissue perfusion by contrast-enhanced ultrasound. Eur Radiol, 2011, 21(3):604-615. [7] Adler DD, Carson PL, Rubin JM, et al. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings. Ultrasound Med Biol, 1990, 16(6):553-559. [8] 李志艳, 汤雨, 李勇武, 等. 超声造影在肝内胆管细胞癌诊断中的应用价值.中华超声影像学杂志, 2016, 25(10):870-874. [9] Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. Am J Roentgenol, 2001, 176(6):1499-1507. [10] Lee JW, Han JK, Kim TK, et al. CT features of intraductal intrahepatic cholangiocarcinoma. Am J Roentgenol, 2000, 175(3):721-725. [11] Jang HJ, Kim TK, Burns PN, et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology, 2007, 244(3):898-906. [12] Chen LD, Xu HX, Xie XY, et al. Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol, 2010, 20(3):743-753. [13] Debruyne EN, Delanghe JR. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta, 2008, 395(1-2):19-26. [14] 王绮, 杨龙, 吴刚, 等. 肝海绵状血管瘤超声造影临床研究. 中华实用诊断与治疗杂志, 2008, 22(12):884-886. [15] 吴剑, 徐辉雄, 郭乐杭, 等. 肝血管瘤超声造影定量特征. 中华医学超声杂志(电子版), 2016, 13(5):371-377. [16] Kunze G, Staritz M, Kohler M. Contrast-enhanced ultrasound in different stages of pyogenic liver abscess. Ultrasound Med Biol, 2015,41(4):952-959. [17] 潘桔红, 陈文卫, 李蓬, 等. 细菌性肝脓肿不同临床病理分期的超声造影表现.中华医学超声杂志(电子版), 2014, 11(12):22-26. [18] 兰方荣, 洪可. 肝脓肿患者超声造影特点及诊断价值分析. 实用肝脏病杂志, 2020, 23(3):435-438. [19] Lee SC, Kim SJ, Yu MH, et al. Uses of inflammatory markers for differentiation of intrahepatic mass-forming cholangiocarcinoma from liver abscess: case-control study. J Clin Med, 2020, 9(10):3194. [20] 陈漪, 王志明, 任正刚, 等. CA19-9对肝细胞癌和胆管细胞癌的诊断价值. 中华肝脏病杂志, 2006, 14(4):299-300. [21] Sasaki K, Margonis GA, Andreatos N, et al. Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma. HPB (Oxford), 2018, 20(10):956-965. |